Search by Drug Name or NDC

    NDC 00078-0434-05 Focalin 40 mg/1 Details

    Focalin 40 mg/1

    Focalin is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is DEXMETHYLPHENIDATE HYDROCHLORIDE.

    Product Information

    NDC 00078-0434
    Product ID 0078-0434_093870c1-4135-493a-b5b6-01a4c1be545a
    Associated GPIs 61400016107060
    GCN Sequence Number 066611
    GCN Sequence Number Description dexmethylphenidate HCl CPBP 50-50 40 MG ORAL
    HIC3 H2V
    HIC3 Description TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY
    GCN 28933
    HICL Sequence Number 022987
    HICL Sequence Number Description DEXMETHYLPHENIDATE HCL
    Brand/Generic Brand
    Proprietary Name Focalin
    Proprietary Name Suffix XR
    Non-Proprietary Name dexmethylphenidate hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name DEXMETHYLPHENIDATE HYDROCHLORIDE
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category NDA
    Application Number NDA021802
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0434-05 (00078043405)

    NDC Package Code 0078-0434-05
    Billing NDC 00078043405
    Package 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0434-05)
    Marketing Start Date 2005-05-31
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 14.9553
    Pricing Unit EA
    Effective Date 2023-01-04
    NDC Description FOCALIN XR 40 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis